<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01715272</url>
  </required_header>
  <id_info>
    <org_study_id>NER1008-01/2012 (DBC)</org_study_id>
    <nct_id>NCT01715272</nct_id>
  </id_info>
  <brief_title>A Clinical Investigation to Demonstrate the Performance of a New Enema (TF037) in Distal Bowel Cleansing Compared With Fleet Enema</brief_title>
  <official_title>A Clinical Investigation to Demonstrate the Performance of a New Enema (TF037) in Distal Bowel Cleansing Compared With Fleet Enema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norgine</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Norgine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to assess the difference between the performance of a new enema
      (TF037) against Fleet enema in distal bowel cleansing.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Performance of TF037 in distal bowel cleansing compared to Fleet enema using the Harefield Cleansing scale</measure>
    <time_frame>Between 1 to 3 hours following enema administration</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stool output as measured by stool weight</measure>
    <time_frame>up to 1 hour following enema administration</time_frame>
    <description>To compare the stool output (as measured as stool weight) during the 1 hour period following enema administration for TF037 and Fleet enema</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety and tolerability as assessed by use of a Visual Analogue scale (VAS)</measure>
    <time_frame>5 and 30 minutes following enema administration</time_frame>
    <description>To assess the safety (including effects on water homeostasis) and tolerability of this medical device in its intended purpose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stool output over time</measure>
    <time_frame>1 hour following enema administration</time_frame>
    <description>To assess kinetics of bowel movements in relation to stool output over time</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Colonoscopy</condition>
  <arm_group>
    <arm_group_label>Fleet enema</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive Fleet enema as their treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TF037</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive TF037 as their treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TF037</intervention_name>
    <arm_group_label>TF037</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fleet enema</intervention_name>
    <arm_group_label>Fleet enema</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male or female subjects [as determined by medical history, physical
             examination, laboratory test values, vital signs and 12-lead electrocardiograms (ECGs)
             at screening] aged 18 to 60 years.

          -  Non-smokers from 3 months before enema administration and for the duration of the
             clinical investigation.

          -  Body mass index (BMI) ≥ 18 and ≤ 35 kg/m2.

          -  Must voluntarily provide written informed consent to participate in the clinical
             investigation.

          -  Must understand the purposes and risks of the clinical investigation and agree to
             follow the restrictions and schedule of procedures as defined in the clinical
             investigation plan, and as confirmed during the informed consent process.

          -  Female subjects must be postmenopausal (for at least one year and confirmed by a serum
             follicle stimulating hormone (FSH) test at screening), surgically sterile, practising
             true sexual abstinence or must use an effective method of contraception.

          -  Female subjects of child-bearing potential must have a negative serum pregnancy test
             at screening and a negative urine pregnancy test at check-in of each period.

          -  The subject's primary care physician must confirm that there is nothing in their
             medical history that would preclude their enrolment into this clinical investigation.

          -  Must be willing to consent to have data entered into The Over Volunteering Prevention
             System (TOPS).

        Exclusion Criteria:

          -  Subjects with a history or presence of significant cardiovascular disease, pulmonary,
             hepatic, gallbladder or biliary tract, renal, haematologic, gastrointestinal,
             endocrine, immunologic, dermatologic, neurologic or psychiatric disease.

          -  Subjects with a history or presence of organic or functional gastrointestinal
             conditions (e.g. chronic constipation, irritable bowel syndrome, inflammatory bowel
             disease).

          -  Subjects with a clinically relevant history or presence of abnormal gastrointestinal
             motility.

          -  Subjects with a significant history of hereditary bowel disorders.

          -  Subjects with abnormal findings on the digital rectal examination performed at
             screening.

          -  Use of laxatives or motility altering drugs in the 3 months preceding enema
             administration.

          -  Use of any prescription or over-the-counter medication (including vitamins, herbal and
             mineral supplements) within 14 days prior to enema administration (or within 5 half
             lives if longer), with the exception of Investigator-approved hormonal contraceptives,
             hormone replacement therapy (HRT) and occasional paracetamol, aspirin or ibuprofen.

          -  Participation in a clinical drug study during the 30 days preceding enema
             administration in this clinical investigation.

          -  Donation of blood or blood products within 30 days prior to enema administration or
             during the clinical investigation, except as required for this clinical investigation

          -  Pregnant or lactating females.

          -  Any clinically significant illness within 28 days prior to enema administration.

          -  History or presence of any significant drug allergy, or a known allergy or
             contraindication to trisodium citrate, Fleet® enema or midazolam.

          -  Laboratory values at screening which are deemed to be clinically significant, unless
             agreed in advance by the Sponsor's Medical Representative and Principal Investigator.

          -  Positive for human immunodeficiency virus (HIV), hepatitis B or hepatitis C.

          -  Current or history of drug or alcohol abuse within the 12 months prior to enema
             administration, or a positive drugs of abuse test at screening or check-in.

          -  Consumption of alcoholic beverages within 24 hours of check-inor during confinement.

          -  Subjects who, in the opinion of the Investigator, are unsuitable for participation in
             the clinical investigation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronnie Beboso, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>BioKinetic Europe Ltd.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>BioKinetic Europe Ltd</name>
      <address>
        <city>Belfast</city>
        <state>Northern Ireland</state>
        <zip>BT2 7BA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>BioKinetic Europe Ltd</name>
      <address>
        <city>Belfast</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2012</study_first_submitted>
  <study_first_submitted_qc>October 24, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 26, 2012</study_first_posted>
  <last_update_submitted>February 27, 2013</last_update_submitted>
  <last_update_submitted_qc>February 27, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 28, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

